JP2024525610A5 - - Google Patents
Info
- Publication number
- JP2024525610A5 JP2024525610A5 JP2024500477A JP2024500477A JP2024525610A5 JP 2024525610 A5 JP2024525610 A5 JP 2024525610A5 JP 2024500477 A JP2024500477 A JP 2024500477A JP 2024500477 A JP2024500477 A JP 2024500477A JP 2024525610 A5 JP2024525610 A5 JP 2024525610A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- oligonucleotide
- complex according
- optionally
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163219977P | 2021-07-09 | 2021-07-09 | |
| US63/219,977 | 2021-07-09 | ||
| PCT/US2022/073528 WO2023283614A2 (en) | 2021-07-09 | 2022-07-08 | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525610A JP2024525610A (ja) | 2024-07-12 |
| JP2024525610A5 true JP2024525610A5 (OSRAM) | 2025-07-17 |
Family
ID=84802085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024500477A Pending JP2024525610A (ja) | 2021-07-09 | 2022-07-08 | 筋標的化複合体およびジストロフィノパチーを処置するためのその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240209119A1 (OSRAM) |
| EP (1) | EP4367247A4 (OSRAM) |
| JP (1) | JP2024525610A (OSRAM) |
| KR (1) | KR20240035823A (OSRAM) |
| CN (1) | CN118510898A (OSRAM) |
| AU (1) | AU2022307934A1 (OSRAM) |
| CA (1) | CA3226298A1 (OSRAM) |
| IL (1) | IL309909A (OSRAM) |
| MX (1) | MX2024000490A (OSRAM) |
| WO (1) | WO2023283614A2 (OSRAM) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220193250A1 (en) | 2018-08-02 | 2022-06-23 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| US12097263B2 (en) | 2018-08-02 | 2024-09-24 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US11911484B2 (en) | 2018-08-02 | 2024-02-27 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US12370264B1 (en) | 2018-08-02 | 2025-07-29 | Dyne Therapeutics, Inc. | Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject |
| US11168141B2 (en) | 2018-08-02 | 2021-11-09 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| JP7611825B2 (ja) | 2018-08-02 | 2025-01-10 | ダイン セラピューティクス，インコーポレーテッド | ジストロフィン異常症を処置するための筋標的化複合体およびそれらの使用 |
| US12018087B2 (en) | 2018-08-02 | 2024-06-25 | Dyne Therapeutics, Inc. | Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject |
| US12624120B2 (en) | 2020-01-31 | 2026-05-12 | Dyne Therapeutics, Inc. | Anti-transferrin receptor (TfR) antibody and uses thereof |
| US11633498B2 (en) | 2021-07-09 | 2023-04-25 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US11771776B2 (en) | 2021-07-09 | 2023-10-03 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| US11969475B2 (en) | 2021-07-09 | 2024-04-30 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| US11638761B2 (en) | 2021-07-09 | 2023-05-02 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy |
| CN117980006A (zh) | 2021-07-09 | 2024-05-03 | 达因疗法公司 | 用于治疗肌养蛋白病的肌肉靶向复合物和制剂 |
| US11672872B2 (en) | 2021-07-09 | 2023-06-13 | Dyne Therapeutics, Inc. | Anti-transferrin receptor antibody and uses thereof |
| KR20250004770A (ko) | 2022-04-15 | 2025-01-08 | 다인 세라퓨틱스, 인크. | 근긴장성 이영양증을 치료하기 위한 근육 표적화 복합체 및 제제 |
| KR20260044219A (ko) | 2023-07-21 | 2026-04-01 | 매로우 테라퓨틱스, 인크. | 조혈 세포 표적화 접합체 및 관련 방법 |
| CN118546927B (zh) * | 2024-05-29 | 2025-02-25 | 广东省农业科学院动物科学研究所 | 一种靶向敲低鸡SRSF2基因表达的siRNA及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2203173B1 (en) * | 2007-10-26 | 2015-12-23 | Academisch Ziekenhuis Leiden | Means and methods for counteracting muscle disorders |
| JP7611825B2 (ja) * | 2018-08-02 | 2025-01-10 | ダイン セラピューティクス，インコーポレーテッド | ジストロフィン異常症を処置するための筋標的化複合体およびそれらの使用 |
| US20230285586A1 (en) * | 2020-07-23 | 2023-09-14 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
-
2022
- 2022-07-08 IL IL309909A patent/IL309909A/en unknown
- 2022-07-08 CA CA3226298A patent/CA3226298A1/en active Pending
- 2022-07-08 KR KR1020247004286A patent/KR20240035823A/ko active Pending
- 2022-07-08 WO PCT/US2022/073528 patent/WO2023283614A2/en not_active Ceased
- 2022-07-08 JP JP2024500477A patent/JP2024525610A/ja active Pending
- 2022-07-08 MX MX2024000490A patent/MX2024000490A/es unknown
- 2022-07-08 US US18/577,462 patent/US20240209119A1/en active Pending
- 2022-07-08 EP EP22838586.0A patent/EP4367247A4/en active Pending
- 2022-07-08 AU AU2022307934A patent/AU2022307934A1/en active Pending
- 2022-07-08 CN CN202280060816.6A patent/CN118510898A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024527362A5 (OSRAM) | ||
| JP2024525611A5 (OSRAM) | ||
| JP2024525613A5 (OSRAM) | ||
| JP2024525612A5 (OSRAM) | ||
| IL309909A (en) | Muscle targeting complexes and uses thereof for treating dystrophinopathies | |
| IL309937A (en) | Muscle targeting complexes and uses thereof for treating dystrophinopathies | |
| JP2023510350A5 (OSRAM) | ||
| IL309912A (en) | Muscle targeting complexes and uses thereof for treating dystrophinopathies | |
| IL309935A (en) | Muscle targeting complexes and uses thereof for treating dystrophinopathies | |
| IL309911A (en) | Muscle targeting complexes and uses thereof for treating dystrophinopathies | |
| JP2023535073A5 (OSRAM) | ||
| US20240325558A1 (en) | Muscle targeting complexes and uses thereof for treating myotonic dystrophy | |
| US11771776B2 (en) | Muscle targeting complexes and uses thereof for treating dystrophinopathies | |
| US12624120B2 (en) | Anti-transferrin receptor (TfR) antibody and uses thereof | |
| JP2023509793A5 (OSRAM) | ||
| US20240117356A1 (en) | Muscle targeting complexes and uses thereof for treating myotonic dystrophy | |
| US20230285586A1 (en) | Muscle targeting complexes and uses thereof for treating dystrophinopathies | |
| JP2024540199A5 (OSRAM) | ||
| IL309936A (en) | Muscle targeting complexes and formulations for the treatment of dystrophinopathy | |
| JP2024524222A5 (OSRAM) | ||
| IL316143A (en) | Muscle targeting complexes and formulations for the treatment of myotonic dystrophy | |
| JP2024540199A (ja) | ジストロフィノパチーを処置するための筋標的化複合体 | |
| IL316206A (en) | Dosage of muscle targeting complexes for the treatment of myotonic dystrophy | |
| JP2026503873A (ja) | Ｄｍｄ遺伝子のエクソン４５をスキップするための筋肉標的化複合体およびその使用 | |
| CN116789820A (zh) | 一种新型免疫调节剂的开发和应用 |